Adult Obesity Management

Introduction

Overweight and obesity have reached epidemic proportions globally, with serious health consequences and significant economic burden. The World Health Organization estimates that more than 1.9 billion adults were overweight in 2016, with over 650 million classified as obese. These conditions are associated with numerous chronic diseases and complications that can significantly impact quality of life and reduce life expectancy.

Effective management of overweight and obesity requires a comprehensive approach that addresses the multifactorial nature of these conditions. Healthcare providers play a crucial role in identifying patients at risk, evaluating potential comorbidities, and implementing evidence-based treatment strategies tailored to individual needs.

Identification of Overweight and Obesity

Accurate identification of overweight and obesity is the first step in effective management. Healthcare providers should routinely assess body weight status using validated screening measures during encounters with adult patients.

Body Mass Index (BMI)

Body Mass Index is the most commonly used metric for assessing overweight and obesity in adults. BMI categories are:

• Underweight: BMI less than 18.5 kg/m
• Normal weight: BMI 18.5-24.9 kg/m
• Overweight: BMI 25.0-29.9 kg/m
• Obesity class I: BMI 30.0-34.9 kg/m
• Obesity class II: BMI 35.0-39.9 kg/m
• Obesity class III: BMI 40.0 kg/m or higher

While BMI is a useful screening tool, it does not directly measure body fat and may misclassify individuals with high muscle mass. Healthcare providers should use BMI as one component of a broader assessment approach.

Waist Circumference

Waist circumference measures abdominal fat and is an important indicator of cardiometabolic risk independent of BMI. The following thresholds indicate elevated risk: Men 102 cm (40 inches), Women 88 cm (35 inches).

Other Measures

Additional assessment tools may include waist-to-hip ratio, body fat percentage measurements, and assessment of patient history and family risk factors. Clinicians should also monitor weight changes over time, noting patterns of weight gain or loss during health assessments.

Evaluation of Overweight and Obesity

Once overweight or obesity has been identified, a comprehensive evaluation should be conducted to assess overall health status, comorbid conditions, and potential contributing factors. This evaluation forms the foundation for developing an appropriate treatment plan.

Medical History

• Weight history, including patterns of weight gain/loss and previous weight loss attempts
• Dietary habits and eating patterns
• Physical activity levels and exercise habits
• Medication use that may affect weight
• Family history of obesity and related conditions
• Psychosocial factors, including stress, depression, and social support

Physical Examination

• Blood pressure and heart rate
• Waist circumference measurement
• Signs of obesity-related complications (e.g., skin changes, joint problems)

Laboratory Assessment

• Lipid profile (total cholesterol, LDL, HDL, triglycerides)
• Fasting blood glucose or hemoglobin A1c
• Thyroid function tests if indicated
• Liver function tests
• Kidney function assessment

Comorbidity Assessment

• Type 2 diabetes or impaired glucose tolerance
• Hypertension
• Dyslipidemia
• Cardiovascular disease
• Sleep apnea
• Osteoarthritis
• Nonalcoholic fatty liver disease

Treatment of Overweight and Obesity

Treatment of overweight and obesity should be individualized based on the patient's health status, preferences, and readiness to make lifestyle changes. The primary goals are modest, sustained weight loss (typically 5-10% of initial body weight) and improvement in obesity-related comorbidities.

Lifestyle Modification

Pharmacotherapy

Medications may be considered for patients with BMI 30 or BMI 27 with comorbidities. FDA-approved options include orlistat, phentermine/topiramate, naltrexone/bupropion, liraglutide, semaglutide, and setmelanotide (for specific genetic conditions). Medication selection should consider potential side effects, contraindications, patient preferences, and cost.

Bariatric Surgery

Bariatric surgery may be appropriate for severe obesity (BMI 40 or BMI 35 with comorbidities). Procedures include Roux-en-Y gastric bypass, sleeve gastrectomy, adjustable gastric banding, and biliopancreatic diversion with duodenal switch. Bariatric surgery typically results in substantial, sustained weight loss and improvement or resolution of many obesity-related comorbidities.

Prevention Strategies

Preventing the development of overweight and obesity is essential for public health. Healthcare providers should promote prevention through:

• Routine monitoring of weight and BMI
• Providing anticipatory guidance regarding weight-gain prevention
• Encouraging healthy eating patterns from early childhood
• Promoting regular physical activity throughout the lifespan
• Advocating for environmental and policy changes that support healthy behaviors

Community-based interventions that address the broader determinants of obesity, including food environments, transportation systems, and socioeconomic factors, are crucial for prevention at the population level.

Resources and Support

Effective management of overweight and obesity often requires multidisciplinary support and ongoing resources. Healthcare providers should connect patients with registered dietitians, exercise professionals, and behavioral health specialists while maintaining ongoing support and follow-up to monitor progress and adjust treatment plans as needed.